Undiagnosed or unlinked HIV-and/or HCV-infected populations still remain an issue worldwide. Integrated, bundled, rapid HCV/HIV testing has been proposed, but testing recommendations slightly differ between the two diseases: HCV testing is recommended for high-risk groups and all persons born between 1945 and 1965; HIV testing is recommended for everyone between the ages of 13 and 64. Our objective is to evaluate which HCV self-reported risk factors are associated with higher rates of infection, considering age as differences may exist. We also focus on creating an easy-to-implement score.
We conducted a sub-analysis of the DRIVE03 study (NCT03145753), which was carried out at four primary care centers, including non HIV-infected people aged, 18 and 70 years. After participants completed an HIV/HCV risk questionnaire, HCV screening was performed using rapid tests for these with any positive response and all participants between 50 and 70 years. Two multivariable models were created, one for participants younger than 50 and other for these older than 50. These models included the questions that exhibited the strongest association with a positive HCV result in the univariate analysis
A total of 7,936 questionnaires were completed and 4,705 HCV tests were performed, 46 of these (0.98%) were positive. Model identified, four out of the 22 questions, that predicted 90% of HCV status for participants younger than 50: HIV- or HCV-infected partner OR 26.6 95% CI (7.6–92.9), Male Sex Male 3.3 (0.8–13.5), illicit or recreational drug use 23.6 (4.2–131.8), and hepatitis or unexplained liver disease 51.0 (17.4–154.9). For patients over 50, five questions predicted 89% of HCV status: male gender 3.1 (1.4–7.2), illicit or recreational drug use 18.1 (4.2–77.8), the belief that there is any possibility of being HIV/HCV infeted 3.2 (1.4–7.5), a previous lymphoma 19.4 (2.1–183.3), and hepatitis or unexplained liver disease 20.8 (8.6 – 50.3). Nomograms appear in Figure
Two easy-to-implement models that are age adapted can predict the majority of HCV status, in general population. This work contributes to the implementation of integrated, bundled, rapid HCV/HIV testing programs.